Literature DB >> 15996361

Total laparoscopic aortofemoral bypass as a routine procedure for the treatment of aortoiliac occlusive disease.

Judith C Lin1, Ralf Kolvenbach, Elisabeth Schwierz, Sergej Wassiljew.   

Abstract

The purpose of our study was to evaluate whether total laparoscopic aortofemoral bypass can be performed routinely in patients who require surgical intervention for aortoiliac occlusive disease. In a prospective study, 68 consecutive patients underwent total laparoscopic aortofemoral bypass between 2002 and 2004. Among these patients, there were 50 men and 18 women, with a mean age of 68.4 +/- 9 years. The mean operating time was 199 minutes, with a mean aortic cross-clamp time of 85.8 minutes. There were five major complications (7.3%). The mean postoperative hospital stay was 6.3 days. Most of the younger patients could be discharged on the third or fourth postoperative day. Our results show that total laparoscopic aortic surgery can be offered as a routine procedure to the majority of patients with long-segment aortoiliac occlusive disease.

Entities:  

Mesh:

Year:  2005        PMID: 15996361     DOI: 10.1258/rsmvasc.13.2.80

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  3 in total

1.  Retroperitoneal approach via paramedian incision for aortoiliac occlusive disease.

Authors:  Bilgin Emrecan; Gokhan Onem; Erkin Ocak; Murat Arslan; Baki Yagci; Ahmet Baltalarli; Beyza Akdag
Journal:  Tex Heart Inst J       Date:  2010

2.  Robot-assisted laparoscopic surgery of the infrarenal aorta : the early learning curve.

Authors:  J Diks; D Nio; V Jongkind; M A Cuesta; J A Rauwerda; W Wisselink
Journal:  Surg Endosc       Date:  2007-03-01       Impact factor: 4.584

Review 3.  Totally laparoscopic aortobifemoral bypass surgery in the treatment of aortoiliac occlusive disease or abdominal aortic aneurysms - a systematic review and critical appraisal of literature.

Authors:  Ingeborg Helgetveit; Anne H Krog
Journal:  Vasc Health Risk Manag       Date:  2017-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.